EmtinB
Pre-clinical- Indications
- Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Spinal Injury, Optic Neuropathies
Company intelligence / Profile preview
NeuroScientific Biopharmaceuticals
Cottesloe, Western Australia, Australianeuroscientific.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
NeuroScientific Biopharmaceuticals has reported promising preclinical data for its lead peptide drug candidate, EmtinB, showing neuroprotective and neuroregenerative effects in models of Alzheimer’s disease and other neurodegenerative conditions. The company claims breakthrough results suggesting potential for disease-modifying therapy in Alzheimer's and significant promise in other indications such as multiple sclerosis, glaucoma, optic neuropathies, ALS, spinal injury, and Parkinson's disease. No clinical trial results have been published yet.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- PeptidesPeptide-based drug
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Covance – preclinical studies partnerLion's Eye Institute – ophthalmology research partnerMenzies Institute for Medical Research – neuroscience research collaboration
Beyond the preview
Go deeper on NeuroScientific Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuroScientific Biopharmaceuticals.